VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
EXPO
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
EXPOExponent, Inc.
$64.46$3.1B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
  1. Home
  2. Financial Ratios

  1. Home
  2. Stocks
  3. EXPO
  4. Financial Ratios

Exponent, Inc. (EXPO) Financial Ratios

Latest Ratios: P/E Ratio 31.1x · EV/EBITDA 23.0x · ROE 26.1%. (1996–2025 historical series)

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly

EXPO Valuation Multiples

Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Market Cap$3.1B$3.6B$4.6B$4.5B$5.2B$6.2B$4.8B$3.8B$2.7B$1.9B$1.6B
Enterprise Value$3.0B$3.5B$4.4B$4.4B$5.0B$5.9B$4.6B$3.6B$2.6B$1.8B$1.5B
P/E Ratio →31.1433.8942.1445.3850.5661.4458.0846.0537.5346.1734.66
P/S Ratio5.376.188.218.4710.0913.3512.009.107.125.525.20
P/B Ratio8.469.2110.8912.7716.1514.9313.2810.848.616.645.99
P/FCF25.5629.3833.3240.9663.3652.8748.8244.6636.1130.4031.17
P/OCF23.7427.2931.7235.7055.2249.9846.4735.1429.6528.2824.47

P/E links to full P/E history page with 30-year chart

EXPO EV Ratios

Enterprise-value multiples — capital-structure-neutral measures of total business value

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
EV / Revenue—5.947.898.179.8112.7511.568.746.795.164.83
EV / EBITDA23.0126.6134.1036.4934.0651.4951.3039.6526.3622.9022.39
EV / EBIT24.9423.4629.9132.2838.1047.2255.5442.8228.1824.9024.60
EV / FCF—28.2532.0339.5261.6150.4747.0242.8634.4128.4228.98

EXPO Profitability

Margins and return-on-capital ratios measuring operating efficiency

Margins

Full margin charts and quarterly trend are on the Earnings History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Gross Margin25.0%25.0%25.5%25.3%32.0%26.6%24.0%93.8%93.4%94.8%95.0%
Operating Margin20.6%20.6%21.4%20.7%27.4%23.4%20.8%20.4%24.1%20.7%19.6%
Net Profit Margin18.2%18.2%19.5%18.7%19.9%21.7%20.6%19.8%19.0%11.9%15.1%

Return on Capital

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
ROE26.1%26.1%28.1%29.6%27.7%26.0%23.2%24.8%24.0%14.7%17.7%
ROA13.4%13.4%15.3%16.3%16.1%15.8%14.3%16.0%15.9%9.8%12.0%
ROIC36.3%36.3%40.7%44.5%67.7%51.3%32.7%33.2%39.1%33.5%31.4%
ROCE19.2%19.2%21.8%24.4%29.4%21.6%18.2%21.0%25.5%21.5%19.6%

EXPO Leverage & Debt

Solvency and debt-coverage ratios — lower is generally safer

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Debt / Equity0.210.210.190.080.060.040.060.07———
Debt / EBITDA0.640.640.630.240.130.130.230.26———
Net Debt / Equity—-0.36-0.42-0.45-0.45-0.68-0.49-0.43-0.40-0.43-0.42
Net Debt / EBITDA-1.07-1.07-1.37-1.32-0.97-2.45-1.97-1.66-1.30-1.59-1.69
Debt / FCF—-1.14-1.29-1.43-1.75-2.40-1.80-1.79-1.70-1.98-2.19
Interest Coverage———————————

Net cash position: cash ($222M) exceeds total debt ($83M)

EXPO Liquidity & Efficiency

Short-term solvency ratios and asset-utilisation metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Current Ratio2.402.402.742.342.202.963.132.943.323.393.42
Quick Ratio2.402.402.742.342.202.963.132.943.323.393.42
Cash Ratio1.251.251.591.161.021.952.071.872.122.112.17
Asset Turnover—0.720.720.830.870.680.670.740.810.790.78
Inventory Turnover———————————
Days Sales Outstanding—113.83105.48113.80120.97109.48101.83105.11101.76115.55101.26

EXPO Shareholder Yields

Earnings, FCF, buyback, and dividend yields — total returns to shareholders

Dividends

Full dividend history and growth charts are on the Dividend History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Dividend Yield1.9%1.7%1.3%1.2%1.0%0.7%0.8%0.9%1.0%1.1%1.1%
Payout Ratio58.1%58.1%53.4%53.9%48.1%42.7%48.2%40.6%37.7%52.9%39.6%

Total Shareholder Return Metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Earnings Yield3.2%3.0%2.4%2.2%2.0%1.6%1.7%2.2%2.7%2.2%2.9%
FCF Yield3.9%3.4%3.0%2.4%1.6%1.9%2.0%2.2%2.8%3.3%3.2%
Buyback Yield3.1%2.7%0.1%0.5%3.0%0.1%0.8%0.6%1.0%0.6%1.5%
Total Shareholder Yield5.0%4.4%1.4%1.7%4.0%0.8%1.7%1.5%2.0%1.8%2.6%
Shares Outstanding—$51M$52M$52M$52M$53M$53M$54M$54M$54M$54M

Key Metrics

Growth RegimeAccelerating
ProfitabilityStable
Balance SheetFortress
Cash FlowMixed
Top Statement Risk

Talent cost inflation pressure

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Margin Volatility Masks Stable Core

Gross margin swung from 16.4% in 2025Q2 to 20.6% in 2026Q2, but excluding reimbursable expenses, underlying profitability appears stable, as reported in recent financial statements.

The wide quarterly swings in gross margin—from 16.4% to 94.5%—are largely attributable to the pass-through nature of reimbursable expenses, which inflate revenue without contributing to profit. Excluding these, the core consulting margin likely hovers in the mid-20s, consistent with the 20.6% reported in 2026Q2. Operating margin of 16.3% in 2026Q2, down from 24.9% in 2026Q1, reflects timing of project costs and utilization, but the 10-quarter average suggests a stable mid-20s operating margin. Investors should focus on revenue before reimbursements to gauge true earning power, as the reported figures overstate top-line growth and understate margin stability.

ROIC Oscillates on Project Timing

ROIC ranged from 4.7% in 2025Q2 to 12.8% in 2025Q1, per reported figures, indicating that quarterly returns are heavily influenced by lumpy project revenue and working capital swings.

The 10-quarter ROIC series shows no clear trend, oscillating between 4.7% and 12.8%, which suggests that the company's return on invested capital is not compounding but rather fluctuating with the timing of large engagements. The 2026Q2 ROIC of 7.0% is below the 2025Q1 peak of 12.8%, but this is partly due to a higher invested capital base from retained earnings. The asset-light model, with PP&E only 21% of total assets, means ROIC is driven primarily by margin and asset turnover, both of which are subject to project mix. A more meaningful measure may be ROE, which at 9.4% in 2026Q2 is consistent with the prior year's 8.3%, indicating stable shareholder returns despite quarterly noise.

Working Capital Swings Drive Cash Flow

DSO rose to 110 days in 2026Q2 from 106 in 2024Q2, while DPO fell to 21 days from 21, per financial statements, indicating that cash conversion is heavily dependent on collection timing.

The cash conversion cycle is not calculable due to missing DIO data, but the DSO trend—hovering around 110 days—suggests that the company extends significant credit to clients, typical of litigation and project-based work. The sharp swings in operating cash flow, from -$45.5M in 2026Q1 to +$18.7M in 2026Q2, reflect the lumpy nature of collections on large engagements. DPO of 21 days is low, indicating that the company pays suppliers promptly, which is consistent with a service model with minimal payables. The efficiency of working capital management appears to be a secondary concern to the timing of major project milestones, which investors should monitor as a source of quarterly volatility.

Debt Creeps Up as Equity Contracts

Debt-to-equity rose from 0.21 in 2025Q4 to 0.28 in 2026Q2, while total debt remained near $81M, as reported, indicating leverage is increasing due to equity contraction from buybacks.

The modest increase in D/E is not a sign of financial distress but rather a mechanical result of aggressive share repurchases reducing equity. With interest coverage not reported, the absence of debt service concerns is supported by the fortress balance sheet, which includes $66.6M in cash and no significant debt maturities. The D/EBITDA ratio of 2.63 in 2026Q2 is elevated relative to the 0.82 in 2024Q1, but this is due to lower EBITDA from margin compression, not increased borrowing. The company's ability to generate strong cash flow and its conservative capital allocation suggest that leverage remains a non-issue, but investors should monitor whether buybacks continue to outpace earnings growth, which could erode the equity buffer.

Liquidity Cushion Compresses but Holds

Current ratio fell from 2.40 in 2025Q4 to 1.98 in 2026Q2, while cash dropped to $66.6M, per balance sheet data, but the company still maintains a comfortable liquidity cushion.

The decline in the current ratio from 2.40 to 1.98 is driven by a reduction in cash and marketable securities, which were deployed into buybacks and dividends. Despite the drawdown, a current ratio of nearly 2.0 indicates that current assets cover current liabilities twice over, providing ample buffer for operational needs. The quick ratio equals the current ratio, reflecting minimal inventory, which is typical for a service firm. Under a severe stress scenario, such as a prolonged downturn in litigation demand, the company's lack of debt and substantial cash reserves would allow it to maintain operations without external financing. The liquidity position remains strong, though the trend warrants monitoring if cash continues to decline.

P/E Misleads on Event-Driven Earnings

The P/E of 33.9 appears rich, but as reported in financial statements, earnings are subject to lumpy project timing and reimbursable revenue, making EV/EBITDA a more reliable valuation metric.

The most commonly misapplied ratio for EXPO is the P/E multiple, which is distorted by the inclusion of reimbursable expenses in revenue and the volatility of net income due to project timing. A trailing P/E of 33.9 and forward P/E of 33.76 suggest a premium valuation, but this may overstate the cost of the stock if earnings are temporarily depressed. EV/EBITDA of 25.16, while still high, better captures the company's operating profitability by excluding non-operating items and the impact of cash holdings. Investors should also consider the PEG ratio of 5.69, which implies that the market is pricing in minimal growth, yet the company is accelerating. A more appropriate approach is to use EV/EBITDA on a normalized basis, adjusting for reimbursables and stock-based compensation, to assess the true earnings power.

Download Financial Ratios Data

Includes 30+ ratios · 30 years · Updated daily

Consensus & Technical Research Suite
Open EXPO Terminal

EXPO Chart Terminal

WASM

Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.

Launch Terminal

Live Breakouts Feed

LIVE

High-probability breakout stocks crossing their pivot across 5 pattern engines.

Explore Setups

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

EXPO — Frequently Asked Questions

Quick answers to the most common questions about buying EXPO stock.

What is Exponent, Inc.'s P/E ratio?

Exponent, Inc.'s current P/E ratio is 31.1x. The historical average is 28.2x. This places it at the 62th percentile of its historical range.

What is Exponent, Inc.'s EV/EBITDA?

Exponent, Inc.'s current EV/EBITDA is 23.0x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 18.1x.

What is Exponent, Inc.'s ROE?

Exponent, Inc.'s return on equity (ROE) is 26.1%. This is above the typical threshold of 15-20% considered good for most companies. The historical average is 16.5%.

Is EXPO stock overvalued?

Based on historical data, Exponent, Inc. is trading at a P/E of 31.1x. This is at the 62th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.

What is Exponent, Inc.'s dividend yield?

Exponent, Inc.'s current dividend yield is 1.86% with a payout ratio of 58.1%.

What are Exponent, Inc.'s profit margins?

Exponent, Inc. has 25.0% gross margin and 20.6% operating margin. Operating margin above 20% indicates strong pricing power and cost efficiency.

How much debt does Exponent, Inc. have?

Exponent, Inc.'s Debt/EBITDA ratio is 0.6x, indicating low leverage. A ratio below 2x is generally considered financially healthy.